Honest (NASDAQ:HNST – Get Free Report) and Medifast (NYSE:MED – Get Free Report) are both small-cap consumer staples companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations.
Insider and Institutional Ownership
45.5% of Honest shares are held by institutional investors. Comparatively, 95.5% of Medifast shares are held by institutional investors. 9.4% of Honest shares are held by insiders. Comparatively, 3.7% of Medifast shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Valuation and Earnings
This table compares Honest and Medifast”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Honest | $371.32 million | 1.37 | -$15.69 million | $0.69 | 6.78 |
| Medifast | $385.79 million | 0.35 | -$18.67 million | ($3.69) | -3.31 |
Honest has higher earnings, but lower revenue than Medifast. Medifast is trading at a lower price-to-earnings ratio than Honest, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of current ratings and recommmendations for Honest and Medifast, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Honest | 1 | 4 | 2 | 2 | 2.56 |
| Medifast | 1 | 2 | 0 | 0 | 1.67 |
Honest currently has a consensus target price of $5.42, suggesting a potential upside of 15.92%. Medifast has a consensus target price of $12.00, suggesting a potential downside of 1.83%. Given Honest’s stronger consensus rating and higher possible upside, equities analysts clearly believe Honest is more favorable than Medifast.
Profitability
This table compares Honest and Medifast’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Honest | 23.47% | 5.10% | 4.03% |
| Medifast | -13.64% | -6.90% | -5.34% |
Volatility & Risk
Honest has a beta of 2.48, suggesting that its share price is 148% more volatile than the S&P 500. Comparatively, Medifast has a beta of 0.65, suggesting that its share price is 35% less volatile than the S&P 500.
Summary
Honest beats Medifast on 13 of the 15 factors compared between the two stocks.
About Honest
The Honest Company, founded in 2011 by Jessica Alba and entrepreneur Brian Lee, develops consumer products for families with an emphasis on ingredient transparency and thoughtfully designed everyday essentials. The company is headquartered in Los Angeles, California. Its products include disposable diapers and wipes, baby and personal-care items, and household cleaning products. Honest sells through its website and retail partners, serving customers primarily in the United States and Canada. Carla VernĂ³n became the company’s chief executive officer in 2023.
About Medifast
Medifast, Inc. is a health and wellness company focused on weight management and healthy living. Its products and programs are marketed primarily under the OPTAVIA brand. OPTAVIA offers structured plans that combine portion-controlled meal replacements and other nutrition products with guidance from independent coaches. The company’s approach emphasizes nutrition, behavior changes and ongoing support. Founded in 1980, Medifast serves customers primarily in the United States. Its business centers on selling products and connecting customers with coaches who provide support as they follow the company’s programs.
Receive News & Ratings for Honest Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Honest and related companies with MarketBeat.com's FREE daily email newsletter.
